N-terminal phosphatase of soluble epoxide hydrolase forms anandamide from anandamide phosphate
Abstract
Soluble epoxide hydrolase exhibits two distinct activities: C-terminal epoxide hydrolase (C-EH) and N-terminal phosphatase (N-phos). Epoxy fatty acids are the primary substrates of C-EH and exhibit anti-inflammatory properties. N-phos hydrolyses lipid phosphate monoesters, such as isoprenoid pyrophosphates, lysophosphatidic acid (LPA), and sphingosine-1-phosphate (S1P). We found that inhibiting both sEH activities, rather than just C-EH, suppressed vascular endothelial cell (VEC) activation. A negatively charged polar lipid (NCPL) fraction from mouse liver extracts also suppressed VEC activation. This effect was canceled by sEH treatment. The inhibition of isoprenoid and nitric oxide synthesis and the treatment with epoxyeicosatrienoic acid, LPAs, and typical S1P did not inhibit VEC activation, suggesting that a metabolite other than these is responsible for suppressing VEC activation. To identify the sEH substrate responsible for this activity, we performed a non-targeted LC-MS/MS analysis using NCPL. As a result, phospho-N-acylethanolamine emerged as a candidate. Enzyme kinetic analysis confirmed that species in this class, including arachidonoyl ethanolamide (anandamide) phosphate, were favorable N-phos substrates. The exogenous addition of anandamide phosphate inhibited VEC activation-associated expression of cell adhesion molecules at concentrations of 3 μM or more.
Related
- The Surrogate Substrate p-Nitrophenyl Phosphate (pNPP) for the Phosphatidylinositol-3-Phosphatase SapM from Mycobacterium tuberculosis: Mutational Analysis of pNPP Hydrolysis and Preliminary Single-Gating Observations
- Direct measurement of PET hydrolase interfacial kinetics reveals catalysis-independent surface remodelling
- Structural and kinetic basis of serine mono-ADP-ribosylation reversal by human ADP-ribosyl-acceptor hydrolase 3
- Mapping bacterial bile amidation across the bile salt hydrolase family
- Structural Insights into the Expanded Substrate Scope of a Cysteine-Dependent Hydrolase from Rhodococcus opacus for Polyethylene, Polypropylene, and Polystyrene Biodegradation
BibTeX
@article{suzuki2026nterminal,
title = {{N-terminal phosphatase of soluble epoxide hydrolase forms anandamide from anandamide phosphate}},
author = {Eriko Suzuki and Hiroki Shidara and Reiji Nagashima and Junki Abe and Ayano Shida and Hitomi Kuwahara and Yuka Uchida and Keiji Hasumi},
journal = {Journal of Biological Chemistry},
year = {2026},
month = sep,
doi = {10.1016/j.jbc.2026.113615},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0021925826024877},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - N-terminal phosphatase of soluble epoxide hydrolase forms anandamide from anandamide phosphate
AU - Eriko Suzuki
AU - Hiroki Shidara
AU - Reiji Nagashima
AU - Junki Abe
AU - Ayano Shida
AU - Hitomi Kuwahara
AU - Yuka Uchida
AU - Keiji Hasumi
PY - 2026
DA - 2026/09/30
JO - Journal of Biological Chemistry
DO - 10.1016/j.jbc.2026.113615
UR - https://linkinghub.elsevier.com/retrieve/pii/S0021925826024877
AB - Soluble epoxide hydrolase exhibits two distinct activities: C-terminal epoxide hydrolase (C-EH) and N-terminal phosphatase (N-phos). Epoxy fatty acids are the primary substrates of C-EH and exhibit anti-inflammatory properties. N-phos hydrolyses lipid phosphate monoesters, such as isoprenoid pyrophosphates, lysophosphatidic acid (LPA), and sphingosine-1-phosphate (S1P). We found that inhibiting both sEH activities, rather than just C-EH, suppressed vascular endothelial cell (VEC) activation. A negatively charged polar lipid (NCPL) fraction from mouse liver extracts also suppressed VEC activation. This effect was canceled by sEH treatment. The inhibition of isoprenoid and nitric oxide synthesis and the treatment with epoxyeicosatrienoic acid, LPAs, and typical S1P did not inhibit VEC activation, suggesting that a metabolite other than these is responsible for suppressing VEC activation. To identify the sEH substrate responsible for this activity, we performed a non-targeted LC-MS/MS analysis using NCPL. As a result, phospho-N-acylethanolamine emerged as a candidate. Enzyme kinetic analysis confirmed that species in this class, including arachidonoyl ethanolamide (anandamide) phosphate, were favorable N-phos substrates. The exogenous addition of anandamide phosphate inhibited VEC activation-associated expression of cell adhesion molecules at concentrations of 3 μM or more.
SN - 0021-9258
SN - 1083-351X
ER -